Brandon P Moss

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Venues

Multiple sclerosis journal - experimental, translational and clinical

Multiple sclerosis (Houndmills, Basingstoke, England)

Cleveland Clinic

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cleveland Clinic Jul 01 2018

United States

Staff Neurologist :: Mellen Center

Publications

John R Ciotti, Dana C Perantie, Brandon P Moss, Kathryn C Fitzgerald, Jeffrey A Cohen, Ellen M Mowry, Robert T Naismith, Salim Chahin
Perspectives and experiences with COVID-19 vaccines in people with MS. Multiple sclerosis journal - experimental, translational and clinical 8 (1) (2022)
Brandon P Moss, Deborah M Miller
Assessing diagnosis disclosure and concealment in multiple sclerosis: Building a framework for moving forward. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (2) (2022)
Deja R Rose, Ahmad Z Mahadeen, Alise K Carlson, Sarah Marie Planchon, Jennifer Sedlak, Scott Husak, Robert A Bermel, Jeffrey A Cohen, Brandon P Moss
Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical 7 (4) (2021)
Brandon P Moss, Kedar R Mahajan, Robert A Bermel, Kelsey Hellisz, Le H Hua, Timothy Hudec, Scott Husak, Marisa P McGinley, Daniel Ontaneda, Zhini Wang, Malory Weber, Paula Tagliani, Simón Cárdenas-Robledo, Anna Zabalza, Georgina Arrambide, Pere Carbonell-Mirabent, Marta Rodríguez-Barranco, Jaume Sastre-Garriga, Mar Tintore, Xavier Montalban, Morgan Douglas, Esther Ogbuokiri, Berna Aravidis, Jeffrey A Cohen, Ellen M Mowry, Kathryn C Fitzgerald
Multiple sclerosis management during the COVID-19 pandemic. Multiple sclerosis (Houndmills, Basingstoke, England) 26 (10) (2020)
Laura E Baldassari, Jenny Feng, Gabrielle Macaron, Sarah Marie Planchon, Ebtesam Alshehri, Brandon P Moss, Daniel Ontaneda, Mary A Willis
Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting. Multiple sclerosis journal - experimental, translational and clinical 5 (3) (2019)
Brandon P Moss, Jeffrey A Cohen
The emergence of follow-on disease-modifying therapies for multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 25 (12) (2019)

Brandon P Moss.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Brandon P Moss